Published in

Taylor and Francis Group, OncoImmunology, 9(7), p. e1477460

DOI: 10.1080/2162402x.2018.1477460

Links

Tools

Export citation

Search in Google Scholar

IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q- AML

Journal article published in 2018 by Belen Lopez-Millan, Rafael Diaz de la Guardia, Heleia Roca-Ho, Eduardo Anguita ORCID, Abul B. M. M. K. Islam ORCID, Damia Romero-Moya ORCID, Cristina Prieto ORCID, Francisco Gutierrez-Agüera, Jose Antonio Bejarano-Garcia, Jose Antonio Perez-Simon, Paula Costales, Montse Rovira ORCID, Pedro Marín, Silvia Menendez, Mar Iglesias and other authors.
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO